Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Abstract Background Carbapenem resistant Pseudomonas aeruginosa (P. aeruginosa) is a global health concern that poses a challenge to treat in health care facilities. Ceftazidim/avibactam and ceftolozane/tazobactam have a potential role in treatment of multi-drug resistant phenotypes including carbap...

Full description

Saved in:
Bibliographic Details
Main Authors: Dalia Salem, Ahmed El-Shenawy, Heba Dahroug, Manar Zaiton, Doaa Gamal, Manal Diab
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Infectious Diseases
Subjects:
Carbapenem resistant P. aeruginosa
Modified carbapenem inactivation method test
Ceftazidim/avibactam
Ceftolozane/tazobactam
β-Lactam/β-Lactamase inhibitor combinations
Online Access:https://doi.org/10.1186/s12879-025-10891-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12879-025-10891-w

Similar Items